Australia's #1 provider of free, online, accredited CPD education

Alzheimer’s disease diagnosis and management are poised for great change. The advent of blood-based biomarkers heralds a new era in Alzheimer’s disease diagnosis and has implications for the role of primary care. Additionally, disease-modifying medication for Alzheimer’s disease has recently been…

Oral corticosteroid (OCS) overuse in asthma is common and harmful. While effective for acute exacerbations and severe asthma, widespread and excessive use of OCS can cause significant side effects. This module aims to raise primary care practitioners' awareness of oral corticosteroid overuse in asthma, its risks, and to help them reduce and prevent unnecessary OCS use in both acute and chronic care.

Severe asthma affects up to 10% of asthma patients and has a significant impact on individuals and the healthcare system. Unlike milder asthma, it has distinct underlying mechanisms and requires specific management. Diagnosis is made by excluding other conditions and ensuring optimal treatment of contributing factors. If asthma remains uncontrolled despite high-dose therapy, guidelines recommend referral for specialist assessment and consideration of monoclonal antibody treatment.

This clinical audit activity presents latest evidence-based recommendations and PBS pathways for reducing cardiorenal risk in people with type 2 diabetes and comorbid cardiovascular disease, multiple cardiovascular risk factors and/or kidney disease. It also provides a practical framework for optimising the care of patients with T2D who are facing enhanced cardiorenal risk, using lifestyle and guideline-directed medical therapies.

Mild cognitive impairment (MCI) is an increasingly prevalent condition in Australia, and GPs can play a key role in its identification and management through early diagnosis and action. This module explores how to identify risk factors and make a diagnosis of MCI, and outlines the effective development of treatment plans for MCI in primary care.

In this clinical audit, you will review the management of 5 patients with established atherosclerotic cardiovascular disease (ASCVD) who are overweight or obese, with reference to Australian and international best practice guidelines, and evaluate how you can further reduce their residual risk of an ASCVD event.